United Therapeutics Corporation
Compounds and methods for delivery of prostacyclin analogs
Last updated:
Abstract:
This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.
Status:
Grant
Type:
Utility
Filling date:
6 Oct 2021
Issue date:
5 Apr 2022